• Cholesterol Restricts Lipid Nanoparticle Trafficking

  2026-09-25

  A sensitive DNA-tracking and imaging platform revealed that cholesterol-rich lipid nanoparticles can accumulate in peripheral early endosomes and show impaired progression along the endolysosomal pathway. The findings distinguish cholesterol-associated trafficking effects from simply increasing ionizable lipid and suggest that helper-lipid balance is relevant when interpreting LNP delivery efficiency.

• HBTU for Enzyme-Responsive Peptide Synthesis

  2026-09-25

  HBTU supports rapid, low-racemization-risk peptide bond formation for researchers building enzyme-responsive peptide sequences and amphiphiles. This guide connects practical coupling choices to a dual-enzyme cancer-selectivity study while distinguishing synthesis recommendations from the study’s biological findings.

• One-step TUNEL Cy5 Apoptosis Detection Kit Guide

  2026-09-24

  Connect DNA-fragmentation imaging to practical apoptosis workflows in cultured cells and tissue sections, with Cy5 readout options for microscopy and flow cytometry. This guide also explains how to use TUNEL as a complementary endpoint—not a substitute for pathway-specific measurements—in studies of TBK1 and type I interferon signaling.

• LNP Charge and V-ATPase Shape Nucleic Acid Delivery

  2026-09-24

  A 2026 study proposes that lipid nanoparticle (LNP) surface charge and target-cell V-ATPase activity jointly influence functional nucleic acid delivery, with contrasting patterns in cultured cells and in vivo organs. The findings connect cell-state biology to nanoparticle tropism and suggest that delivery studies should evaluate both particle properties and endo/lysosomal function.

• FGFR Crosstalk Controls Periostin in HER2+ Breast Cancer

  2026-09-24

  Labrèche et al. show that periostin expression in HER2-positive breast cancer cells is regulated by interacting FGFR, TGFβ, and PI3K/AKT signals. Their findings identify FGFR-mediated repression and SMAD-independent TGFβ induction as complementary controls, clarifying how tumor cells may acquire a periostin-positive state.

• TBST: Uses, Mechanism, and Workflow Guide

  2026-09-23

  TBST, or Tris-Buffered Saline and Tween 20, is an isotonic buffered salt solution used for blocking and washing in antibody-based assays. Its Tween 20 component can reduce nonspecific binding and support signal-to-noise ratio enhancement, while product specifications report pH 7.4 and room-temperature stability for 12 months.

• GDC-0068 (RG7440) Akt Pathway Workflow

  2026-09-22

  Build reproducible PI3K/Akt/mTOR experiments with GDC-0068 (RG7440), from dose-response and phospho-signaling assays to spatial mTORC1 studies. The workflow emphasizes biomarker selection, paradoxical phospho-Akt behavior, and controls that distinguish pathway suppression from compartment-specific effects.

• Super-Enhancer RNA Drives Nasopharyngeal Cancer Metastasis

  2026-09-22

  A 2023 study identifies the carcinogen-induced seRNA-NPCm as an active regulator of nasopharyngeal carcinoma metastasis. By integrating RNA-seq, GRO-seq, ChIP-seq, perturbation experiments, and patient-tissue analyses, the authors connect super-enhancer activity with an NPM1/c-Myc/NDRG1 transcriptional axis.

• SU5416: From VEGFR2 Biology to Translation

  2026-09-21

  SU5416 (Semaxanib) is more than a conventional angiogenesis tool: it enables controlled interrogation of VEGFR2-dependent endothelial biology while also offering an AHR-linked immune dimension. This article connects its established cancer research applications with emerging insights into vascular remodeling, including the AURKB-centered pulmonary hypertension study by Lemay et al., while defining practical safeguards for translational interpretation.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding

  2026-09-21

  A 2025 study identified naturally occurring angiotensin fragments as modulators of SARS-CoV-2 spike-protein binding to AXL, ACE2, and neuropilin-1. Its peptide-length and tyrosine-modification experiments provide a structure–activity framework for connecting renin-angiotensin system research with antiviral receptor biology, while remaining primarily in vitro evidence.

• Indole-3-pyruvic acid: Bench Workflows

  2026-09-20

  Indole-3-pyruvic acid gives researchers a practical handle on auxin flux, TAA1 feedback, and AhR-linked immune assays. This workflow guide connects plant hormone research with translational immune experiments while emphasizing fresh preparation, matched controls, and domain-specific interpretation.

• GDC-0941: From PI3K Biology to Translational Strategy

  2026-09-19

  A translational perspective on using GDC-0941 to interrogate PI3K/Akt signaling, therapy resistance, and pathway-informed combination strategies in cancer research.

• GDC-0941 as a PI3K/Akt Dependency Probe

  2026-09-19

  GDC-0941 is a selective PI3K inhibitor for testing how PI3K/Akt signaling sustains cancer-cell survival, therapy resistance, and stem-like phenotypes. This article connects its pharmacology with the DRD4–Akt–β-catenin model in liver cancer and shows how to choose mechanistically informative assay readouts.

• Angiotensin Peptides and SARS-CoV-2 Receptor Binding

  2026-09-18

  A 2025 study found that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to host receptors, with especially strong effects associated with shorter peptides and angiotensin IV. The work links renin–angiotensin system peptide processing to a biochemical step in viral entry while emphasizing that receptor-binding results do not by themselves establish effects on infection or disease severity.

• Leucovorin Calcium in Gastric Cancer Assays

  2026-09-17

  Leucovorin Calcium, or calcium folinate, can serve as more than a methotrexate rescue reagent. This article explains how to use its folate-bypass biology as an interpretive control in patient-derived gastric cancer assembloid assays and tumor–stroma resistance studies.

7964 records 1/531 page Next 12345 下5页 Last page